OPKO Health Operating Margin 2010-2024 | OPK
OPKO Health Operating Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Operating Income | Operating Margin |
2024-09-30 | $0.71B | $-0.19B | -26.40% |
2024-06-30 | $0.72B | $-0.27B | -37.10% |
2024-03-31 | $0.80B | $-0.20B | -24.63% |
2023-12-31 | $0.86B | $-0.16B | -18.17% |
2023-09-30 | $0.87B | $-0.14B | -16.49% |
2023-06-30 | $0.87B | $-0.17B | -19.24% |
2023-03-31 | $0.91B | $-0.19B | -20.26% |
2022-12-31 | $1.00B | $-0.23B | -22.51% |
2022-09-30 | $1.22B | $-0.23B | -19.18% |
2022-06-30 | $1.43B | $-0.11B | -7.57% |
2022-03-31 | $1.56B | $-0.09B | -5.84% |
2021-12-31 | $1.77B | $0.02B | 1.07% |
2021-09-30 | $1.87B | $0.13B | 7.01% |
2021-06-30 | $1.91B | $0.12B | 6.02% |
2021-03-31 | $1.77B | $0.14B | 7.69% |
2020-12-31 | $1.44B | $0.06B | 3.97% |
2020-09-30 | $1.16B | $-0.10B | -8.93% |
2020-06-30 | $0.97B | $-0.17B | -17.10% |
2020-03-31 | $0.89B | $-0.24B | -26.85% |
2019-12-31 | $0.90B | $-0.27B | -30.30% |
2019-09-30 | $0.90B | $-0.25B | -27.92% |
2019-06-30 | $0.92B | $-0.25B | -26.63% |
2019-03-31 | $0.96B | $-0.20B | -21.19% |
2018-12-31 | $0.99B | $-0.17B | -17.26% |
2018-09-30 | $0.93B | $-0.24B | -25.70% |
2018-06-30 | $0.93B | $-0.25B | -27.43% |
2018-03-31 | $0.96B | $-0.28B | -28.80% |
2017-12-31 | $0.97B | $-0.28B | -28.67% |
2017-09-30 | $0.98B | $-0.19B | -19.77% |
2017-06-30 | $1.03B | $-0.17B | -16.44% |
2017-03-31 | $1.09B | $-0.12B | -10.53% |
2016-12-31 | $1.12B | $-0.10B | -8.77% |
2016-09-30 | $1.22B | $-0.03B | -2.62% |
2016-06-30 | $1.07B | $-0.02B | -1.50% |
2016-03-31 | $0.75B | $-0.07B | -9.18% |
2015-12-31 | $0.49B | $-0.10B | -19.96% |
2015-09-30 | $0.24B | $-0.12B | -50.62% |
2015-06-30 | $0.12B | $-0.16B | -137.29% |
2015-03-31 | $0.10B | $-0.17B | -172.00% |
2014-12-31 | $0.09B | $-0.15B | -157.61% |
2014-09-30 | $0.09B | $-0.15B | -171.26% |
2014-06-30 | $0.09B | $-0.12B | -136.36% |
2014-03-31 | $0.09B | $-0.10B | -117.05% |
2013-12-31 | $0.10B | $-0.08B | -82.47% |
2013-09-30 | $0.09B | $-0.05B | -58.70% |
2013-06-30 | $0.08B | $-0.04B | -53.01% |
2013-03-31 | $0.07B | $-0.04B | -50.72% |
2012-12-31 | $0.05B | $-0.04B | -78.72% |
2012-09-30 | $0.04B | $-0.04B | -94.59% |
2012-06-30 | $0.03B | $-0.03B | -100.00% |
2012-03-31 | $0.03B | $-0.03B | -93.33% |
2011-12-31 | $0.03B | $-0.02B | -82.14% |
2011-09-30 | $0.03B | $-0.01B | -41.38% |
2011-06-30 | $0.03B | $-0.01B | -35.71% |
2011-03-31 | $0.03B | $-0.01B | -40.74% |
2010-12-31 | $0.03B | $-0.01B | -39.29% |
2010-09-30 | $0.02B | $-0.02B | -84.21% |
2010-06-30 | $0.02B | $-0.02B | -120.00% |
2010-03-31 | $0.01B | $-0.02B | -170.00% |
2009-12-31 | $0.00B | $-0.02B | -550.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.085B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $202.480B | 24.70 |
Intuitive Surgical (ISRG) | United States | $196.045B | 102.50 |
Alcon (ALC) | Switzerland | $42.794B | 28.63 |
Edwards Lifesciences (EW) | United States | $42.188B | 26.79 |
IQVIA Holdings (IQV) | United States | $36.777B | 20.26 |
IDEXX Laboratories (IDXX) | United States | $35.676B | 42.01 |
DexCom (DXCM) | United States | $30.357B | 45.72 |
Waters (WAT) | United States | $22.803B | 33.72 |
STERIS (STE) | Ireland | $21.310B | 24.53 |
SONOVA HOLDING (SONVY) | Switzerland | $20.157B | 0.00 |
Hologic (HOLX) | United States | $17.098B | 18.47 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $14.119B | 14.49 |
Sysmex ADR (SSMXY) | Japan | $13.255B | 0.00 |
Globus Medical (GMED) | United States | $11.345B | 28.73 |
Penumbra (PEN) | United States | $9.105B | 89.18 |
Masimo (MASI) | United States | $9.091B | 43.99 |
Teleflex (TFX) | United States | $8.576B | 13.68 |
Glaukos (GKOS) | United States | $7.735B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $4.949B | 0.00 |
Integer Holdings (ITGR) | United States | $4.675B | 26.50 |
Veracyte (VCYT) | United States | $3.420B | 102.63 |
Inari Medical (NARI) | United States | $2.990B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.699B | 15.58 |
Nihon Kohden (NHNKY) | Japan | $2.361B | 17.93 |
TransMedics (TMDX) | United States | $2.291B | 72.62 |
Elekta AB (EKTAY) | Sweden | $2.165B | 19.47 |
Tandem Diabetes Care (TNDM) | United States | $1.978B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
RxSight (RXST) | United States | $1.739B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.365B | 0.00 |
Artivion (AORT) | United States | $1.243B | 82.39 |
Pulse Biosciences (PLSE) | United States | $1.215B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.849B | 14.43 |
Paragon 28 (FNA) | United States | $0.840B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
IRadimed (IRMD) | United States | $0.687B | 37.11 |
Mesa Laboratories (MLAB) | United States | $0.674B | 15.88 |
AxoGen (AXGN) | United States | $0.656B | 0.00 |
SiBone (SIBN) | United States | $0.567B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
Semler Scientific (SMLR) | United States | $0.512B | 30.12 |
Treace Medical Concepts (TMCI) | United States | $0.494B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.439B | 23.75 |
Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
NeuroPace (NPCE) | United States | $0.337B | 0.00 |
CVRx (CVRX) | United States | $0.327B | 0.00 |
AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
Inogen (INGN) | United States | $0.226B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
Accuray (ARAY) | United States | $0.202B | 0.00 |
Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.174B | 0.00 |
Nevro (NVRO) | United States | $0.157B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.145B | 15.49 |
Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.095B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.092B | 0.00 |
LENSAR (LNSR) | United States | $0.089B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
InspireMD (NSPR) | Israel | $0.080B | 0.00 |
908 Devices (MASS) | United States | $0.080B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
Hyperfine (HYPR) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
Envoy Medical (COCH) | United States | $0.045B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.040B | 0.00 |
Spectral AI (MDAI) | United States | $0.039B | 0.00 |
Neuronetics (STIM) | United States | $0.039B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
DarioHealth (DRIO) | United States | $0.026B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
NexGel (NXGL) | United States | $0.024B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
Nuwellis (NUWE) | United States | $0.006B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |